Insights From the PLCO Trial About Prostate Cancer Screening

被引：2
|
作者：
Gulati, Roman [1 ]
Albertsen, Peter C. [2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA
[2] Univ Connecticut, Ctr Hlth, Dept Surg, Div Urol, Farmington, CT USA
来源：
CANCER | 2017年 / 123卷 / 04期
关键词：
RANDOMIZED PROSTATE; MORTALITY; ERSPC;
D O I：
10.1002/cncr.30472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [1] Lethal Prostate Cancer in the PLCO Cancer Screening Trial
    Shoag, Jonathan
    Mittal, Sameer
    Halpern, Joshua A.
    Scherr, Douglas
    Hu, Jim C.
    Barbieri, Christopher E.
    EUROPEAN UROLOGY, 2016, 70 (01) : 2 - 5
  • [2] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [3] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10): : 722 - 731
  • [4] Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial
    Miller, Eric A.
    Pinsky, Paul F.
    Black, Amanda
    Andriole, Gerald L.
    Pierre-Victor, Dudith
    PROSTATE, 2018, 78 (11) : 830 - 838
  • [5] Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Blacka, Amanda
    Kramer, Barnett S.
    Miller, Anthony
    Prorok, Philip C.
    Berg, Christine
    CLINICAL TRIALS, 2010, 7 (04) : 303 - 311
  • [6] Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial
    Pinsky, Paul F.
    Parnes, Howard L.
    Andriole, Gerald
    BJU INTERNATIONAL, 2014, 113 (02) : 254 - 259
  • [7] Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial
    Shoag, Jonathan
    Halpern, Joshua
    Eisner, Brian
    Lee, Richard
    Mittal, Sameer
    Barbieri, Christopher E.
    Shoag, Daniel
    JAMA ONCOLOGY, 2015, 1 (07) : 983 - 986
  • [8] ERSPC and PLCO Prostate Cancer Screening Studies: What Are the Differences?
    Schroder, Fritz H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2010, 58 (01) : 46 - 52
  • [9] Screening for Prostate Cancer: Practical Analysis of the ESRPC and PLCO Trials
    Djavan, Bob
    EUROPEAN UROLOGY, 2011, 59 (03) : 365 - 369
  • [10] Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Marcus, Pamela M.
    Ogden, Sheryl L.
    Gren, Lisa H.
    Childs, Jeffery C.
    Pretzel, Shannon M.
    Lamerato, Lois E.
    Walsh, Kayo
    Rozjabek, Heather M.
    Mabie, Jerome
    Thomas, Brett
    Riley, Tom
    PREVENTIVE MEDICINE, 2014, 67 : 82 - 88
12345